Monday, October 10, 2022 8:41:35 PM
Bureau Staff
October 10, 2022
This story was reprinted with permission from Crain’s Chicago and written by John Pletz.
Board members weren’t the only ones who resigned last week from marijuana company Green Thumb Industries (OTC: GTBIF).
The company’s general counsel, Beth Burk, also departed, according to a U.S. Securities & Exchange Commission filing made Oct. 7. Burk was a chief compliance officer at Aon before joining Green Thumb, one of Chicago’s largest cannabis companies, in early 2020.
Burk resigned Oct. 4, along with three of GTI’s four independent directors: YMCA of Metropolitan Chicago CEO Dorri McWhorter; William Gruver, a former Bucknell University professor and Goldman Sachs executive; and Glen Senk, a private-equity executive. All three were members of the company’s audit committee.
The company said when it announced the board changes, “the resigning directors informed management that their cause for resignation was not related to Green Thumb’s business performance, operations, financial performance, financial statements or financial controls, but rather over a disagreement as to the company’s policies and practices related to personal misconduct. It became clear that the former directors and existing management could not find a resolution satisfactory to all parties.”
GTI didn’t provide any details on the circumstances around Burk’s departure, nor did it respond to a request for comment.
“It’s not a good sign when the audit committee and general counsel depart in one fell swoop,” says Charles Elson, a corporate governance expert and retired professor of finance at the University of Delaware.
In its regulatory filing, the company disclosed the terse resignation letter from the three board members, which was written by Senk, a former CEO of Urban Outfitters who joined GTI when it went public in 2018. “We confirm our resignations from the Green Thumb board of directors as of 11:59 PM CT on October 3, 2022, because of our material differences with company management,” the letter states. “This correspondence supersedes our prior written correspondence to you on this matter.”
SEC filings did not contain any previous correspondence. The company also said in its filing that Jeff Goldman, one of two board members selected to replace those who resigned, has been working for GTI as a marketing consultant since November.
Recent GTBIF News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:32:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:32:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:31:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:31:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:31:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:05:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:21:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:19:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:12:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:11:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:10:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:08:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:07:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:04:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM